The Natural Fungal Metabolite Beauvericin Exerts Anticancer Activity In Vivo: A Pre-Clinical Pilot Study
dc.contributor.author | Heilos, Daniela | |
dc.contributor.author | Rodríguez-Carrasco, Yelko | |
dc.contributor.author | Englinger, Bernhard | |
dc.contributor.author | Timelthaler, Gerald | |
dc.contributor.author | Van Schoonhoven, Sushilla | |
dc.contributor.author | Sulyok, Michael | |
dc.contributor.author | Boecker, Simon | |
dc.contributor.author | Süßmuth, Roderich D. | |
dc.contributor.author | Heffeter, Petra | |
dc.contributor.author | Lemmens-Gruber, Rosa | |
dc.contributor.author | Dornetshuber-Fleiss, Rita | |
dc.contributor.author | Berger, Walter | |
dc.date.accessioned | 2019-09-16T14:48:00Z | |
dc.date.available | 2019-09-16T14:48:00Z | |
dc.date.issued | 2017-08-24 | |
dc.date.updated | 2019-07-31T17:25:59Z | |
dc.description.abstract | Recently, in vitro anti-cancer properties of beauvericin, a fungal metabolite were shown in various cancer cell lines. In this study, we assessed the specificity of this effect by comparing beauvericin cytotoxicity in malignant versus non-malignant cells. Moreover, we tested in vivo anticancer effects of beauvericin by treating BALB/c and CB-17/SCID mice bearing murine CT-26 or human KB-3-1-grafted tumors, respectively. Tumor size and weight were measured and histological sections were evaluated by Ki-67 and H/E staining as well as TdT-mediated-dUTP-nick-end (TUNEL) labeling. Beauvericin levels were determined in various tissues and body fluids by LC-MS/MS. In addition to a more pronounced activity against malignant cells, we detected decreased tumor volumes and weights in beauvericin-treated mice compared to controls in both the allo- and the xenograft model without any adverse effects. No significant differences were detected concerning percentages of proliferating and mitotic cells in tumor sections from treated and untreated mice. However, a significant increase of necrotic areas within whole tumor sections of beauvericin-treated mice was found in both models corresponding to an enhanced number of TUNEL-positive, i.e., apoptotic, cells. Furthermore, moderate beauvericin accumulation was detected in tumor tissues. In conclusion, we suggest beauvericin as a promising novel natural compound for anticancer therapy. | en |
dc.identifier.eissn | 2072-6651 | |
dc.identifier.uri | https://depositonce.tu-berlin.de/handle/11303/10023 | |
dc.identifier.uri | http://dx.doi.org/10.14279/depositonce-9014 | |
dc.language.iso | en | en |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | en |
dc.subject.ddc | 610 Medizin und Gesundheit | de |
dc.subject.other | cyclohexadepsipeptide | en |
dc.subject.other | beauvericin | en |
dc.subject.other | cervix carcinoma | en |
dc.subject.other | colorectal carcinoma | en |
dc.subject.other | therapy | en |
dc.title | The Natural Fungal Metabolite Beauvericin Exerts Anticancer Activity In Vivo: A Pre-Clinical Pilot Study | en |
dc.type | Article | en |
dc.type.version | publishedVersion | en |
dcterms.bibliographicCitation.articlenumber | 258 | en |
dcterms.bibliographicCitation.doi | 10.3390/toxins9090258 | en |
dcterms.bibliographicCitation.issue | 9 | en |
dcterms.bibliographicCitation.journaltitle | Toxins | en |
dcterms.bibliographicCitation.originalpublishername | MDPI | en |
dcterms.bibliographicCitation.originalpublisherplace | Basel | en |
dcterms.bibliographicCitation.volume | 9 | en |
tub.accessrights.dnb | free | en |
tub.affiliation | Fak. 2 Mathematik und Naturwissenschaften::Inst. Chemie::FG Biologische Chemie | de |
tub.affiliation.faculty | Fak. 2 Mathematik und Naturwissenschaften | de |
tub.affiliation.group | FG Biologische Chemie | de |
tub.affiliation.institute | Inst. Chemie | de |
tub.publisher.universityorinstitution | Technische Universität Berlin | en |